Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Sep 2012. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 70554001000001115 | Amphotericin liposomal (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 70554101000001119 | Amphotericin liposomal | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 70850901000001114 | Amphotericin B liposomal | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amphotericin liposomal | Is a | Amphotericin | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Amphotericin B liposomal 50mg powder for dispersion for infusion vials | Has specific active ingredient | True | Amphotericin liposomal | Inferred relationship | Existential restriction modifier | |
| AmBisome Liposomal 50mg powder for dispersion for infusion vials (Gilead Sciences Ltd) | Has specific active ingredient | True | Amphotericin liposomal | Inferred relationship | Existential restriction modifier | |
| Amphotericin B liposomal 50mg powder for dispersion for infusion vials 10 vial | Has specific active ingredient | True | Amphotericin liposomal | Inferred relationship | Existential restriction modifier | |
| AmBisome Liposomal 50mg powder for dispersion for infusion vials (Gilead Sciences Ltd) 10 vial | Has specific active ingredient | True | Amphotericin liposomal | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR